Nectar Lifesciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Nectar Lifesciences has a total shareholder equity of ₹10.7B and total debt of ₹6.4B, which brings its debt-to-equity ratio to 59.4%. Its total assets and total liabilities are ₹21.9B and ₹11.2B respectively. Nectar Lifesciences's EBIT is ₹969.8M making its interest coverage ratio 1.2. It has cash and short-term investments of ₹203.0M.
Belangrijke informatie
59.4%
Verhouding schuld/eigen vermogen
₹6.36b
Schuld
| Rente dekkingsratio | 1.2x |
| Contant | ₹203.01m |
| Aandelen | ₹10.69b |
| Totaal verplichtingen | ₹11.22b |
| Totaal activa | ₹21.91b |
Recente financiële gezondheidsupdates
Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
Jul 27
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Recent updates
Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive
Oct 11Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth
Aug 22Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
Jul 27Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Feb 19Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?
Feb 25Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Zooming in on NSE:NECLIFE's 0.3% Dividend Yield
Nov 02Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Sep 07
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today
Aug 09The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More
Aug 09What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E
Jul 13Analyse van de financiële positie
Kortlopende schulden: NECLIFE's short term assets (₹12.8B) exceed its short term liabilities (₹9.7B).
Langlopende schulden: NECLIFE's short term assets (₹12.8B) exceed its long term liabilities (₹1.5B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: NECLIFE's net debt to equity ratio (57.5%) is considered high.
Schuld verminderen: NECLIFE's debt to equity ratio has reduced from 82.8% to 59.4% over the past 5 years.
Schuldendekking: NECLIFE's debt is well covered by operating cash flow (35.4%).
Rentedekking: NECLIFE's interest payments on its debt are not well covered by EBIT (1.2x coverage).